October 23, 2009 (FinancialWire) — Jiangbo Pharmaceuticals, Inc. (OTCBB: JGBO), a pharmaceutical company, said that Haibo Xu resigned as its chief operating officer for health reasons. The company said it has initiated a search for a replacement candidate for COO.

Xu will continue in his role as a member of Jiangbo’s board.

Laiyang, China-based Jiangbo Pharmaceuticals is engaged in the research, development, production, marketing and sales of pharmaceutical products in China.

The company, whose operations are located in Eastern China, produces both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary form.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.